Chu Vicki H, Tetzlaff Michael T, Torres-Cabala Carlos A, Prieto Victor G, Bassett Roland, Gershenwald Jeffrey E, McLemore Michael S, Ivan Doina, Wang Wei-Lien Billy, Ross Merrick I, Curry Jonathan L
Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA.
Section of Dermatopathology, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Biomed Res Int. 2013;2013:898719. doi: 10.1155/2013/898719. Epub 2013 Dec 3.
The 7th (2009) edition of the AJCC melanoma staging system incorporates tumor (Breslow) thickness, MR, and ulceration in stratifying T1 primary melanomas. Compared to the prior 6th (2001) edition, MR has replaced CL for thin melanomas.
We sought to identify and report differences of the classification of thin melanomas as well as outcome of SLNB in patients according to the 6th and 7th editions at our institution.
106 patients were identified with thin melanomas verified by wide excision. 31 of 106 thin melanomas were reclassified according to the 7th edition of the AJCC. Of those 31, 15 CL II/III patients (6th edition T1a) were reclassified as T1b based on the presence of mitoses while 16 CL IV patients (6th edition T1b) were categorized as T1a based on the absence of mitoses. 26/31 reclassified patients underwent SLNB, and all were negative. Patients with thin melanoma and a +SLNB (N = 3) were all classified as T1b according to both staging systems.
In our experience, 29% of thin melanomas were reclassified according to the 7th edition with similar proportions of patients re-distributed as T1a (14%) and T1b (15%). Cases with +SLN corresponded with T1b lesions in both 6th and 7th editions.
美国癌症联合委员会(AJCC)黑色素瘤分期系统第7版(2009年)在对T1期原发性黑色素瘤进行分层时纳入了肿瘤(Breslow)厚度、有丝分裂率(MR)和溃疡情况。与之前的第6版(2001年)相比,对于薄型黑色素瘤,有丝分裂率取代了Clark分级(CL)。
我们试图识别并报告在我们机构中,根据第6版和第7版分期系统,薄型黑色素瘤分类的差异以及前哨淋巴结活检(SLNB)的结果。
106例经广泛切除证实为薄型黑色素瘤的患者被纳入研究。106例薄型黑色素瘤中有31例根据AJCC第7版进行了重新分类。在这31例中,15例Clark分级II/III期患者(第6版T1a)基于有丝分裂的存在被重新分类为T1b,而16例Clark分级IV期患者(第6版T1b)基于无有丝分裂被分类为T1a。31例重新分类的患者中有26例接受了前哨淋巴结活检,结果均为阴性。薄型黑色素瘤且前哨淋巴结活检阳性(N = 3)的患者根据两种分期系统均被分类为T1b。
根据我们的经验,29%的薄型黑色素瘤根据第7版进行了重新分类,重新分配为T1a(14%)和T1b(15%)的患者比例相似。前哨淋巴结阳性的病例在第6版和第7版中均与T1b病变相对应。